Shimmer secures $10m wearable tech contract

Trade
Pictured: Shimmer3. Source: Shimmer

24 March 2014

Shimmer, a Dublin-based provider of wearable sensor technology, has secured a long-term supply contract with US medical device developer Emerge Diagnostics. Worth $10 million over the next three years, Shimmer will provide an open source software platform Emerge Diagnostics will use in its Electrodiagnostic Functional Assessment (EFA) device.

The announcement follows Shimmer’s release of Shimmer3 (pictured), a wireless body sensor platform for personal health which received the 2013 Frost & Sullivan Product Leadership Award for its flexible body-worn wireless sensing platform.

The EFA – which has been approved by the US Food and Drug Agency – can distinguish an acute from a chronic injury and can assist with better treatment and even identify when an injury originally occurred. It uses 28 wearable sensors harvesting a whole range of movement and bio-physical data, including includes sensors for electromyography, strain/force gauges and motion capture sensors. The nature and amount of data collected can help in the the development of diagnostic solutions than can be customised to the level of individual cases.

Robert Thompson, CEO of Emerge Diagnostics, said: “Shimmer and its technology has been central to our new FDA-cleared soft tissue diagnostic instrument. Emerge plans to ship over 2,000 units in the next three years, creating a completely new product and service category.”

Shimmer CEO Paddy White said: “Shimmer has been working closely with Emerge Diagnostics for a number of years to develop their Shimmer-based solution for muscle injury profiling. We’ve got to know the Emerge team really well primarily through our Boston facility, and our relationship has resulted in their product achieving FDA approval. With pent up demand already in the market, we expect strong growth over the next three years, and we are looking forward to the upswing this will have on Shimmer’s output.”

TechCentral Reporters

Read More:


Leave a Reply

Back to Top ↑